SOLV
Solventum (SOLV)
NYSE
$74.00+$0.44 (+0.59%)
Price as of Jun 23, 2026 6:30 PM EDT
  • $12.7B
    Market Cap
  • 0.42%
    1-Year Change
  • Medical Instruments & Supplies
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
6.3B
-23.08%
8.3B
N/A
Cost of Revenue
3.4B
-18.96%
4.2B
N/A
Gross Profit
4.5B
-3.09%
4.6B
N/A
Sales and Marketing Expense
3.1B
+10.71%
2.8B
N/A
Research and Development Expense
-739.0M
-4.65%
-775.0M
N/A
Depreciation and Amortization Expense
489.0M
-11.89%
555.0M
N/A
Total Operating Expenses
3.4B
-18.96%
4.2B
N/A
Operating Profit
2.2B
+110.52%
1.0B
N/A
Interest Income
N/A
N/A
N/A
N/A
Interest Expense
-347.0M
-5.45%
-367.0M
N/A
Interest Income and Expense and Net
-347.0M
-5.45%
-367.0M
N/A
Total Nonoperating Income and Expense
-39.0M
-39.06%
-64.0M
N/A
Income before Taxes
1.7B
+183.14%
605.0M
N/A
Income Taxes
157.0M
+23.62%
127.0M
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
1.6B
+224.84%
479.0M
N/A
Net Income from Continuing Operations Applicable to Common
1.7B
+183.14%
605.0M
N/A
Basic EPS and Net Income
8.94
+222.74%
2.77
N/A
Diluted EPS and Net Income
8.88
+221.74%
2.76
N/A
Basic Weighted Average Shares
174.1M
+0.52%
173.2M
N/A
Diluted Weighted Average Shares
175.3M
+0.92%
173.7M
N/A
Balance Sheet
Cash and Cash Equivalents
878.0M
+15.22%
762.0M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
878.0M
+15.22%
762.0M
N/A
Total Current Assets
3.9B
+18.78%
3.2B
N/A
Accumulated Depreciation
1.9B
-6.09%
2.0B
N/A
Property and Plant and Equipment and Net
1.3B
-18.25%
1.6B
N/A
Total Long-Term Assets
814.0M
+22.41%
665.0M
N/A
Total Assets
14.3B
-1.13%
14.5B
N/A
Income Taxes Payable
164.0M
-27.11%
225.0M
N/A
Total Short-Term Debt
0
-100.00%
200.0M
N/A
Total Current Liabilities
3.1B
+16.02%
2.7B
N/A
Total Long-Term Debt
5.0B
-35.53%
7.8B
N/A
Total Long-Term Liabilities
547.0M
+33.41%
410.0M
N/A
Total Liabilities
9.2B
-19.59%
11.5B
N/A
Retained Earnings
1.8B
+642.56%
242.0M
N/A
Total Stockholders Equity
5.0B
+70.63%
3.0B
N/A
Total Shares Outstanding
173.5M
+0.41%
172.8M
N/A
Cash Flow
Cash from Operating Activities
369.0M
-68.86%
1.2B
N/A
Capital Expenditures
379.0M
-0.26%
380.0M
N/A
Cash from Investing Activities
2.8B
+836.05%
-380.0M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
-3.1B
+1,173.75%
-240.0M
N/A
Financials Ratio
Gross Margin
46.42%
N/A
N/A
N/A
Operating Margin
34.35%
N/A
N/A
N/A
Return on Assets
10.82%
N/A
N/A
N/A
Return on Equity
38.86%
N/A
N/A
N/A
Revenue Growth
-23.08%
N/A
N/A
N/A
Current Ratio
1.23
N/A
N/A
N/A
Cash Ratio
0.28
N/A
N/A
N/A
Debt-to-Equity Ratio
1.00
N/A
N/A
N/A
Debt-to-Assets Ratio
0.35
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow